Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sage Therapeutics

6.70
+0.10001.52%
Volume:647.39K
Turnover:4.31M
Market Cap:419.56M
PE:-1.16
High:6.72
Open:6.52
Low:6.44
Close:6.60
Loading ...

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and SAGE Therapeutics (SAGE)

TIPRANKS
·
13 Jan

Hold Rating for SAGE Therapeutics Amid Biogen Acquisition Offer and Pipeline Challenges

TIPRANKS
·
13 Jan

Sage Therapeutics confirms $7.22 per share acquisition proposal from Biogen

TIPRANKS
·
11 Jan

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal From Biogen

THOMSON REUTERS
·
11 Jan

BUZZ-Sage Therapeutics soars after Biogen makes $441.7 mln bid for company

Reuters
·
11 Jan

Biogen Inc Reports 10.2% Stake in Sage Therapeutics Inc as of Jan 10, 2025

THOMSON REUTERS
·
11 Jan

Biogen Inc - Submits Non-Binding Proposal to Buy All Outstanding Shares of Sage Therapeutics' Common Stock Not Owned by Biogen for $7.22/Share in Cash

THOMSON REUTERS
·
11 Jan

Biogen Inc Says on January 10, Delivered Letter to Sage Therapeutics' CEO - SEC Filing

THOMSON REUTERS
·
11 Jan

RBC Raises Price Target on SAGE Therapeutics to $5 From $4, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
07 Jan

Wall Street Analysts Believe Sage Therapeutics (SAGE) Could Rally 42.02%: Here's is How to Trade

Zacks
·
06 Jan

Sage Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
03 Jan

Sage Therapeutics price target lowered to $9 from $26 at Piper Sandler

TIPRANKS
·
02 Jan

Sage Therapeutics (SAGE) Surges 12.2%: Is This an Indication of Further Gains?

Zacks
·
23 Dec 2024

Sage Therapeutics price target lowered to $6 from $10 at Stifel

TipRanks
·
17 Dec 2024

Sage Therapeutics Is Maintained at Hold by Stifel

Dow Jones
·
16 Dec 2024